首页 > 市场调查报告书 > 医疗设备

眼科设备

市场调查报告书

商品编码

2008909

人工水晶体市场报告：按产品、材料、应用和地区划分（2026-2034 年）

Intraocular Lens Market Report by Product, Material (Polymethylmethacrylate, Silicone, Hydrophobic Acrylic), End Use, and Region 2026-2034

出版日期: 2026年04月01日 | 出版商:

IMARC | 英文 139 Pages | 商品交期: 2-3个工作天内

价格

简介目录图表

2025年，全球人工水晶体市场规模达46亿美元。展望未来，IMARC集团预测，到2034年，该市场规模将达到67亿美元，2026年至2034年的复合年增长率（CAGR）为4.14%。 2025年，北美市场占据主导地位，这得益于其先进的医疗基础设施和持续的技术创新。人口老化导致白内障发病率上升，加上全球眼科保健意识的增强和普及，推动了对先进手术治疗的需求，从而提升了人工水晶体市场的份额。

市场规模及预测：

2025年，人工水晶体市场价值将达到46亿美元。
预计从 2026 年到 2034 年，该市场将以 4.14% 的复合年增长率成长，到 2034 年达到 67 亿美元。

主要部分：

产品：多焦点人工水晶体（IOL）凭藉其在不同距离提供清晰视力以及减少白内障手术后对眼镜的依赖性，在市场上占据主导地位。这使其成为追求便利性和提高生活品质人士的首选。
材质：疏水性丙烯酸酯因其优异的生物相容性、较低的后囊膜混浊风险和卓越的光学透明度而占据最大的市场份额。其能够保持长期稳定性并防止沉积，使其成为外科医生的首选材料，从而改善白内障和屈光矫正手术的视觉效果和患者满意度。
最终用途：该医院作为白内障手术的主要中心，拥有最先进的手术设备和专业的眼科医生，在市场上具有明显的优势。其管理大量患者的能力、提供全面的术前术后护理以及实施尖端的人工水晶体（IOL）技术，确保了对人工水晶体的稳定需求。
区域：北美市场占据领先地位，这主要得益于其白内障高发病率、先进的医疗基础设施以及高端人工水晶体的广泛普及。完善的保险报销机制、人们对视力矫正方案日益增长的认知以及主要市场参与者的存在，都进一步加速了该地区的成长。

主要企业：

人工水晶体市场的主要企业包括爱尔康、博士伦健康公司、卡尔蔡司医疗技术公司（卡尔蔡司基金会）、Icon Medical、HOYA Corporation、Human Optics、强生公司、Lenstec、Rayner Intraocular Lenses 和 Star Surgical。

市场成长的主要驱动因素：

白内障发病率不断上升，尤其是在老年族群中，这显着推动了对人工水晶体（IOL）的需求。由于白内障仍然是全球视力障碍的主要原因之一，越来越多的患者需要接受手术治疗。
眼科医疗设施的扩建：眼科医疗设施的快速扩建提高了白内障和屈光矫正手术的可及性，并增加了人工水晶体的使用。配备最新手术器械和技术精湛的专家的先进设施确保了更好的治疗效果，吸引了更多患者前来就诊。
生活型态相关眼科疾病激增：长时间使用电子萤幕正在加速年轻一代出现视力障碍，包括屈光不正。这一趋势扩大了人工水晶体植入手术的潜在患者群。眼部疲劳、蓝光照射和户外活动减少是推动矫正手术需求的主要因素。
技术进步：人工水晶体（IOL）的创新，例如多焦点晶状体、散光矫正水晶体和调节型水晶体，显着提高了视力，并减少了对眼镜的依赖。先进的影像技术和雷射辅助技术提高了手术精度，从而提升了患者满意度。
扩大眼科治疗的保险覆盖范围：扩大白内障手术和人工水晶体植入的保险覆盖范围，降低了经济门槛，使更多人能够获得治疗。保险报销制度鼓励及时手术，并允许患者选择优质晶体。

未来展望：

强劲成长前景：受白内障患者数量不断增加、人口老化以及先进晶体技术广泛应用等因素的推动，人工水晶体市场预计将持续成长。医疗保健覆盖范围的扩大、保险政策的完善以及技术创新有望增加手术数量，并进一步加速全球市场普及。
市场演变：预计该领域将从基础的单焦点镜片转向先进的多焦点镜片、散光镜片和可调节镜片，以增强视力矫正效果。雷射辅助手术和高端镜片定制等技术的融合，彻底改变了治疗标准。

推动这一市场发展的因素包括患者对多焦点和散光镜片等先进视力矫正方案的认知度不断提高。文明病相关眼科疾病（尤其是长时间使用电子萤幕导致的眼疾）的增加，是导致视力障碍并需要手术介入的重要因素。眼科手术保险覆盖范围的扩大和优惠的报销政策，使得更多人能够负担得起人工水晶体手术。此外，年轻一代选择性地进行屈光晶体置换术以矫正视力的趋势，也扩大了市场规模。製造商和眼科医师加强行销力度，强调先进人工水晶体的优势，也影响病人的选择。最后，手术安全性和效果的提升，也促使更多人选择晶体置换术。

人工水晶体市场趋势：

白内障患病率增加

白内障盛行率的上升，尤其是在老年族群中，是推动市场成长的主要因素。根据美国疾病管制与预防中心（CDC）预测，到2028年，美国将有超过3,000万人罹患白内障。白内障会导致水晶体混浊，进而造成视力障碍，而手术是目前唯一的矫正方法。随着全球老年人口的增长，白内障手术的数量显着增加，从而推动了对人工水晶体（IOL）的需求。公共卫生措施和政府提供的免费或津贴白内障手术计画正在改善患者获得治疗的机会。手术技术的进步和成功率的提高，促使更多患者选择白内障摘除手术，直接促进了人工水晶体的全球普及。

眼科医疗中心扩建

眼科医疗中心的扩建有助于提高专业眼科服务的可近性。 2025年7月，由董事长兼执行长D. Ramamurti创立的眼科基金会（Eye Foundation）——一个由多家高度专业化的眼科医院组成的网络——在印度清奈的瓦达帕拉尼开设了其第25家分院。该中心提供包括使用高端人工晶体（IOL）的雷射白内障手术以及SILK和飞秒雷射等尖端LASIK技术在内的专业服务。都市区地区医院、诊所和专业眼科医疗机构的增加，使得更多人能够获得白内障和屈光矫正手术。基础设施的改善使得及时诊断和治疗成为可能，这对于白内障等需要手术治疗的疾病至关重要。这些先进医疗中心的建立增强了患者对手术的信心，并鼓励更多人选择视力矫正。

技术进步

技术进步透过为患者提供更佳的视力矫正和更广泛的客製化选择，推动了市场成长。多焦点晶体、景深扩展晶体、散光镜片和调节型人工水晶体（IOL）等创新技术能够更有效地矫正老花眼和散光，从而减少对眼镜的依赖。晶体材料的进步提高了生物相容性并减少了术后併发症，而飞秒雷射白内障手术等精准的手术技术则提高了晶体植入的准确性。 2025年1月，北京亿博医疗科技有限公司及其子公司宣布，其用于有晶状体眼患者的龙晶PR人工水晶体已获得国家药品监督管理局（NMPA）颁发的III类医疗设备认证。龙晶PR采用先进的均衡丙烯酸酯材料製成，具有无球面像差设计、宽光学区和稳定的双凹弓形高度。此外，透过整合数位影像处理和人工智慧（AI）规划工具，外科医师可以实现针对每位患者个别需求的最佳屈光矫正效果。

文明病引起的眼科疾病急剧增加。

长时间使用电子萤幕导致的与文明病的眼科疾病发病率不断上升，正在改善市场前景。过度使用电脑、智慧型手机和电子设备会导致眼睛疲劳、干眼症和视力加速下降，从而加速水晶体相关疾病的发生。视力障碍过去常见于老年人，如今也出现在年轻一代中，这扩大了人工水晶体植入术的潜在患者群体。此外，持续暴露于蓝光和户外活动减少也会影响整体眼部健康，因此需要采取矫正措施。眼科专家建议及时进行手术干预以恢復视力，其中许多手术都涉及植入先进的人工水晶体。这些生活方式的改变正在推动对视力矫正手术的持续需求，从而促进市场成长。

人们对先进视力矫正方案的认识不断提高

随着人们对先进视力矫正方案的认知不断提高，人工水晶体（IOL）的需求也随之增长，因为患者正在寻求恢復清晰视力的长期解决方案。宣传活动和社群媒体推广正在提升大众对白内障手术和屈光水晶体置换术的了解。许多人开始意识到，人工水晶体不仅可以矫正白内障，还可以矫正近视、远视和散光等屈光不正。口碑传播、患者证词以及眼科医生提供的透明资讯进一步增强了人们对这些手术的信心。随着患者了解到有优质的人工水晶体可供选择，从而减少对眼镜的依赖，他们越来越多地选择更早接受手术。这种认知的提高，加上健康意识的增强，直接推动了人工水晶体植入率的提高和市场的稳定成长。

扩大眼科治疗的保险覆盖范围

眼科治疗保险覆盖范围的扩大对市场产生了积极影响，显着降低了视力矫正手术的经济门槛。许多健康保险计划现在涵盖部分或全部白内障手术费用，包括人工水晶体（IOL）的费用。这使得更多人群，包括退休人员和低收入患者，能够更方便地获得先进的人工水晶体。此外，一些国家的保险报销机制鼓励患者及时接受手术，以防止视力丧失并提高生活品质。透过减少自付费用，保险覆盖使患者能够选择具有更佳视觉效果的高端人工水晶体。这不仅提高了市场渗透率，也提升了每次手术的平均收入。随着保险政策不断扩大眼科治疗的覆盖范围，预计对人工水晶体的需求将稳定成长。

The global intraocular lens market size reached USD 4.6 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 6.7 Billion by 2034, exhibiting a growth rate (CAGR) of 4.14% during 2026-2034. North America dominates the market in 2025, driven by advanced healthcare infrastructure and continual technological innovations . The growing aging population with increased cataract incidence and rising global awareness and accessibility to eye care are collectively driving the demand for advanced surgical interventions, thereby propelling the intraocular lens market share.

MARKET SIZE & FORECASTS:

Intraocular lens market was valued at USD 4.6 Billion in 2025.
The market is projected to reach USD 6.7 Billion by 2034, at a CAGR of 4.14% from 2026-2034.

DOMINANT SEGMENTS:

Product: Multifocal intraocular lens (IOL) dominates the market because it provides sharp vision at various distances, decreasing the reliance on glasses post-cataract surgery. This renders it a favored option for individuals looking for ease and improved living standards.
Material: Hydrophobic acrylic represents the biggest market share due to its outstanding biocompatibility, low likelihood of posterior capsule opacification, and superior optical clarity. Its capacity to uphold long-term stability and prevent deposits makes it the preferred material for surgeons, enhancing visual results and patient satisfaction in cataract and refractive surgeries.
End Use: Hospitals exhibit a clear dominance in the market as they act as main hubs for cataract operations, possess state-of-the-art surgical equipment, and hire expert ophthalmologists. Their capacity to manage large patient numbers, provide thorough pre- and post-operative care, and implement cutting-edge intraocular lens (IOL) technologies guarantees a steady need for IOLs.
Region: North America leads the market due to high prevalence of cataracts, advanced healthcare infrastructure, and widespread adoption of premium IOLs. Strong reimbursement systems, higher awareness about vision correction options, and the presence of key market players are further accelerating the region's growth.

KEY PLAYERS:

The leading companies in intraocular lens market include Alcon Inc., Bausch Health Companies Inc., Carl Zeiss Meditec AG (Carl-Zeiss-Stiftung), EyeKon Medical Inc., Hoya Corporation, HumanOptics AG, Johnson & Johnson, Lenstec Inc., Rayner Intraocular Lenses Limited, STAAR Surgical Company, etc.

KEY DRIVERS OF MARKET GROWTH:

Increasing Prevalence of Cataracts: Rising prevalence of cataracts, especially among the aging population, is significantly driving the demand for IOLs. As cataracts remain the leading cause of vision impairment globally, more patients require surgical intervention.
Expansion of Ophthalmic Care Centers: The rapid expansion of ophthalmic care centers is enhancing access to cataract and refractive surgeries, increasing IOL adoption. Advanced facilities equipped with modern surgical tools and trained specialists ensure better outcomes, encouraging more patients to seek treatment.
Surge in Lifestyle-related Eye Conditions: Prolonged screen use is accelerating the onset of vision problems, including refractive errors, among younger individuals. This trend is expanding the potential patient base for IOL surgeries. Eye strain, blue light exposure, and reduced outdoor activities are driving the demand for corrective procedures.
Technological Advancements: Technological innovations in IOLs, such as multifocal, toric, and accommodating designs, provide superior visual outcomes and reduced dependence on glasses. Enhanced surgical precision through advanced imaging and laser-assisted techniques improves patient satisfaction.
Increasing Insurance Coverage for Eye Treatments: Rising insurance coverage for cataract surgeries and IOLs reduces financial barriers, making treatments accessible to wider populations. Reimbursement policies are encouraging timely procedures and enabling patients to choose premium lens options.

FUTURE OUTLOOK:

Strong Growth Outlook: The intraocular lens market is anticipated to experience sustained expansion, driven by increasing cataract cases, aging population, and rising adoption of advanced lens technologies. Expanding healthcare access, supportive insurance policies, and technological innovations are expected to enhance surgical volumes, ensuring greater global penetration.
Market Evolution: The sector is anticipated to shift from basic monofocal designs to advanced multifocal, toric, and accommodating lenses, offering improved visual outcomes. Technological integration, such as laser-assisted surgery and premium lens customization, has transformed treatment standards.

The market is driven by the growing awareness among patients about advanced vision correction options, such as multifocal and toric lenses. Rising lifestyle-related eye conditions, particularly due to prolonged screen exposure, are contributing to vision impairments requiring surgical intervention. Increasing insurance coverage and favorable reimbursement policies for eye surgeries are making IOLs more accessible to a broader population. Additionally, the trend of refractive lens exchange for elective vision correction among younger individuals is widening the market base. Greater marketing efforts by manufacturers and ophthalmologists to highlight the benefits of advanced IOLs are also influencing patient choices. Furthermore, improvements in surgical safety and outcomes are encouraging more people to opt for lens replacement procedures.

INTRAOCULAR LENS MARKET TRENDS:

Increasing prevalence of cataracts

Rising prevalence of cataracts, especially among the aging population, is a major driver for the market. As per the Centers for Disease Control and Prevention (CDC), by the year 2028, it is anticipated that more than 30 Million individuals will be affected by cataracts in the United States. Cataracts cause clouding of the natural lens, leading to vision impairment that can only be corrected through surgery. As the global elderly demographic is growing, the number of cataract surgeries is increasing significantly, driving the demand for IOLs. Public health initiatives and government programs offering free or subsidized cataract surgeries are making treatments more accessible. With improved surgical techniques and higher success rates, more patients are opting for cataract removal, directly fueling the adoption of IOLs worldwide.

Expansion of ophthalmic care centers

The broadening of ophthalmic care centers is aiding in improving accessibility to specialized eye treatments. In July 2025, the Eye Foundation, a network of super-speciality eye hospitals established by D. Ramamurthy, chairman and managing director, inaugurated its 25th facility in Vadapalani, Chennai, India. The center provided specialized services, such as laser cataract surgery featuring premium IOLs and cutting-edge LASIK technologies like SILK and Femto. With more hospitals, clinics, and dedicated eye care facilities opening in both urban and rural areas, a larger population can undergo cataract and refractive surgeries. This improved infrastructure enables timely diagnosis and treatment, which is crucial for conditions like cataracts that require surgical intervention. The presence of advanced care centers is boosting patient confidence in surgical procedures, encouraging more individuals to opt for vision correction.

Technological advancements

Technological advancements are propelling the market growth by offering patients improved visual outcomes and greater customization options. Innovations, such as multifocal, extended depth-of-focus, toric lenses, and accommodating IOLs, provide better correction for presbyopia and astigmatism, reducing dependence on glasses. Advancements in lens materials enhance biocompatibility and reduce post-surgical complications, while precision surgical techniques like femtosecond laser-assisted cataract surgery increase implantation accuracy. In January 2025, Yebright Medical Technology (Beijing) Co., Ltd., along with its subsidiaries, declared that its Phakic IOL, 'Loong Crystal PR,' obtained the Class III Medical Devices Certificate from the National Medical Products Administration (NMPA). Made from an advanced, balanced acrylic material, the Loong Crystal PR featured a zero spherical aberration layout with an extensive optical zone and a stable double concave arch height configuration. Besides this, the integration of digital imaging and artificial intelligence (AI)-based planning tools allows surgeons to achieve optimal refractive results tailored to individual patient needs.

Surge in lifestyle-related eye conditions

Increasing incidence of lifestyle-related eye conditions caused by prolonged screen time is offering a favorable market outlook. Excessive use of computers, smartphones, and digital devices leads to eye strain, dry eyes, and accelerated vision deterioration, contributing to the earlier onset of lens-related disorders. Younger individuals are now experiencing vision impairment that traditionally affected older adults, expanding the potential patient base for IOL surgeries. Additionally, constant exposure to blue light and reduced outdoor activities are known to affect overall eye health, necessitating corrective procedures. Eye care professionals are recommending timely surgical interventions to restore vision, which often involve the implantation of advanced IOLs. This lifestyle shift is catalyzing sustained demand for corrective eye surgeries, thereby fueling the market growth.

Growing awareness about advanced vision correction options

Rising awareness about advanced vision correction options is driving the demand for IOLs, as patients are seeking long-term solutions to restore clear vision. Educational programs and social media outreach have made people more informed about cataract surgery and refractive lens exchange. Many individuals are understanding that IOLs not only treat cataracts but can also correct refractive errors like myopia, hyperopia, and astigmatism. Word-of-mouth recommendations, testimonials, and transparent communication from ophthalmologists further build trust in these procedures. As patients are learning about the availability of premium lens types offering reduced dependence on glasses, they are more likely to choose surgical intervention earlier. This heightened awareness, combined with increased health consciousness, is directly translating into higher adoption rates, thereby impelling steady market growth.

Increasing insurance coverage for eye treatments

Rising insurance coverage for eye treatments is positively influencing the market, as it significantly reduces the financial barrier to vision correction surgeries. Many health insurance policies include partial or full coverage for cataract procedures, including the cost of IOLs. This makes advanced lens options more accessible to a broader demographic, including retirees and low-income patients. Reimbursement policies in several countries also encourage timely surgery, preventing vision loss and improving quality of life. By alleviating out-of-pocket expenses, insurance coverage allows patients to opt for premium IOLs with enhanced visual performance. This is not only boosting the market penetration but also increasing the average revenue per surgery. As insurance policies continue to expand their scope for ophthalmic treatments, the demand for IOLs is expected to grow steadily.

INTRAOCULAR LENS INDUSTRY SEGMENTATION:

Breakup by Product:

Monofocal IOL
Multifocal IOL
Toric IOL
Accommodative IOL

Multifocal IOL account for the majority of the market share

Multifocal IOLs dominate the market as the largest segment, offering a comprehensive solution to age-related vision issues. These lenses provide multiple focal points, allowing patients to achieve clear vision at various distances, reducing dependence on glasses after cataract surgery. With an aging population seeking enhanced visual acuity for both near and far distances, multifocal IOLs have gained prominence. The versatility they offer aligns with the lifestyle demands of individuals desiring improved vision across different activities, from reading to driving, making them a preferred choice in the market.

Monofocal IOLs represent a significant segment of the market, serving as a traditional and cost-effective option for cataract surgery. These lenses have a single focal point, typically set for distance vision, necessitating the use of glasses for activities requiring near vision. While lacking multifocal versatility, monofocal IOLs remain popular due to their reliability and affordability, catering to patients with specific visual needs and budget constraints.

Toric IOLs address astigmatism, a common refractive error, making them a crucial segment in the market. These lenses correct both cataracts and astigmatism simultaneously, enhancing visual outcomes for patients with irregular corneal shapes. With an increasing prevalence of astigmatism globally, toric IOLs have witnessed growing demand, offering patients the opportunity to achieve better visual clarity without additional surgical interventions or reliance on corrective eyewear.

Accommodative IOLs represent an innovative segment designed to mimic the eye's natural ability to adjust focus. These lenses provide a dynamic range of vision by changing shape and position within the eye. While still evolving, accommodative IOLs aim to reduce dependency on glasses for both near and distant vision. As technological advancements continue, this segment holds promise for individuals seeking a more adaptive and natural visual experience post-cataract surgery.

Breakup by Material:

Polymethylmethacrylate (PMMA)
Silicone
Hydrophobic Acrylic

Hydrophobic acrylic holds the largest share of the industry

Hydrophobic acrylic has emerged as the largest segment in the market due to its superior optical properties and biocompatibility. These lenses are known for their resistance to protein and water deposits, reducing the likelihood of postoperative complications. Hydrophobic acrylic IOLs provide excellent clarity and are suitable for various surgical techniques. Surgeons often prefer this material for its ease of handling and the reduced risk of posterior capsule opacification (PCO), contributing to the widespread adoption of hydrophobic acrylic lenses in modern cataract surgeries. The material's ability to maintain optical clarity over time and resist clouding has solidified its position as a leading choice.

PMMA has been a traditional material in intraocular lenses (IOLs) and, while its usage has decreased with technological advancements, it still holds a notable segment in the market. PMMA lenses are rigid and durable, providing stability within the eye. However, their lack of flexibility and potential for certain postoperative complications have led to a decline in their popularity compared to more modern materials like hydrophobic acrylic and silicone.

Silicone lenses offer flexibility and biocompatibility, contributing to their prevalence in the market. Known for their softness and ability to fold easily, silicone lenses facilitate less invasive surgical procedures. The material's inert nature reduces the risk of inflammation and allergic reactions. While not as widely used as hydrophobic acrylic, silicone remains a significant choice, particularly in cases where the surgeon prioritizes lens flexibility and patient comfort.

Breakup by End Use:

Hospitals
Ophthalmic Clinics
Ambulatory Care Centers
Eye Research Institutes

Hospitals represent the leading market segment

Hospitals constitute the largest segment of the market, serving as primary hubs for surgical procedures, including cataract surgeries requiring IOL implantation. The comprehensive infrastructure and diverse medical specialties within hospitals make them central to the diagnosis and treatment of ocular conditions. The high patient footfall in hospitals, coupled with the availability of advanced surgical facilities, positions them as key contributors to the demand for intraocular lenses. Moreover, hospitals often attract a wide range of patients, including those with complex ocular conditions, making them pivotal in the overall market share.

On the other hand, ophthalmic clinics represent a significant segment of the market, offering specialized care focused on eye health. These clinics, led by ophthalmologists and optometrists, are key contributors to the diagnosis and treatment of various eye disorders, including cataracts. Ophthalmic clinics provide a more specialized and focused environment for eye care, attracting patients seeking expert advice and surgical interventions. The efficiency and expertise of these clinics contribute to their substantial share in the IOL market, particularly for routine and elective eye surgeries.

Moreover, ambulatory care centers play a notable role in the market, offering a balance between the comprehensive services of hospitals and the specialized care of ophthalmic clinics. These centers provide outpatient surgical procedures, including cataract surgery with this lens implantation. The convenience of ambulatory care centers, offering timely and efficient procedures without the need for overnight hospital stays, appeals to patients and contributes to the demand for these lenses outside traditional hospital settings.

Furthermore, eye research institutes are crucial contributors to the market. These institutions focus on advancing knowledge in ophthalmology, developing new surgical techniques, and conducting clinical trials for innovative intraocular lens technologies. The insights and advancements generated by eye research institutes influence the broader market, shaping the future of these lens materials, designs, and surgical approaches. While not primary end-users for routine surgeries, these institutes play a pivotal role in driving innovation and elevating the standards of care in the field of ophthalmology.

Breakup by Region:

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa

North America leads the market, accounting for the largest intraocular lens market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America dominates the market, driven by advanced healthcare infrastructure, a high prevalence of cataracts, and a rapidly aging population. The region's well-established reimbursement policies and a strong focus on technological innovations contribute to the widespread adoption of premium IOLs. The presence of key market players, coupled with a proactive approach toward eye health and surgical interventions, solidifies North America's leading position in the global IOL market.

The Asia Pacific region is a significant and growing market for intraocular lenses, fueled by a large population, increasing awareness of eye health, and rising access to healthcare services. The prevalence of age-related eye conditions, including cataracts, in countries like China and India, propels the demand for IOLs. Furthermore, advancements in healthcare infrastructure and the growing disposable income in several Asia Pacific nations contribute to the expansion of the market in the region.

Europe stands as a prominent market for these lenses, driven by a well-established healthcare system, a high prevalence of age-related eye disorders, and a growing emphasis on minimally invasive surgical techniques. The region's aging population contributes significantly to the demand for cataract surgeries and, consequently, intraocular lenses. European countries also exhibit a strong inclination toward adopting innovative medical technologies, fostering the growth of the market in the region.

Latin America represents a burgeoning market for intraocular lenses, propelled by improving healthcare infrastructure and a rising awareness of eye health. The region's aging demographic contributes to an increased incidence of cataracts, driving the demand for lens implantation. While the market is still developing, Latin America showcases substantial growth potential, with increasing investments in healthcare and a growing focus on addressing visual impairments.

The Middle East and Africa exhibit a growing demand for these lenses, driven by improving healthcare accessibility and rising awareness of eye disorders. Although the market is in the early stages of development compared to other regions, an aging population and increasing investments in healthcare infrastructure contribute to the expansion of the market. As these regions continue to advance in medical technology adoption, the demand for intraocular lenses is expected to rise, albeit at a pace influenced by regional economic factors and healthcare development.

LEADING KEY PLAYERS IN THE INTRAOCULAR LENS INDUSTRY:

The key players in the market are actively engaged in strategic initiatives to maintain and expand their market presence. Continuous research and development efforts are directed towards the enhancement of intraocular lens technologies, focusing on improving optical outcomes, durability, and patient satisfaction. Companies are investing in the development of innovative materials and designs, such as advanced hydrophobic acrylics and multifocal lenses, to address evolving patient needs. Additionally, strategic collaborations, partnerships, and acquisitions are prevalent among key players, enabling them to strengthen their product portfolios and leverage complementary technologies. Market leaders are also actively involved in geographic expansion, targeting emerging markets with growing healthcare infrastructures.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Alcon Inc.
Bausch Health Companies Inc.
Carl Zeiss Meditec AG (Carl-Zeiss-Stiftung)
EyeKon Medical Inc.
Hoya Corporation
HumanOptics AG
Johnson & Johnson
Lenstec Inc.
Rayner Intraocular Lenses Limited
STAAR Surgical Company

Key Questions Answered in This Report

1.What is the expected growth rate of the global intraocular lens market during 2026-2034?
2.What are the key factors driving the global intraocular lens market?
3.What has been the impact of COVID-19 on the global intraocular lens market?
4.What is the breakup of the global intraocular lens market based on the product?
5.What is the breakup of the global intraocular lens market based on the material?
6.What is the breakup of the global intraocular lens market based on the end use?
7.What are the key regions in the global intraocular lens market?
8.Who are the key players/companies in the global intraocular lens market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Intraocular Lens Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product

6.1 Monofocal IOL
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Multifocal IOL
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Toric IOL
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
6.4 Accommodative IOL
- 6.4.1 Market Trends
- 6.4.2 Market Forecast

7 Market Breakup by Material

7.1 Polymethylmethacrylate (PMMA)
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Silicone
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Hydrophobic Acrylic
- 7.3.1 Market Trends
- 7.3.2 Market Forecast

8 Market Breakup by End Use

8.1 Hospitals
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Ophthalmic Clinics
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Ambulatory Care Centers
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Eye Research Institutes
- 8.4.1 Market Trends
- 8.4.2 Market Forecast

9 Market Breakup by Region

9.1 North America
- 9.1.1 United States
  - 9.1.1.1 Market Trends
  - 9.1.1.2 Market Forecast
- 9.1.2 Canada
  - 9.1.2.1 Market Trends
  - 9.1.2.2 Market Forecast
9.2 Asia-Pacific
- 9.2.1 China
  - 9.2.1.1 Market Trends
  - 9.2.1.2 Market Forecast
- 9.2.2 Japan
  - 9.2.2.1 Market Trends
  - 9.2.2.2 Market Forecast
- 9.2.3 India
  - 9.2.3.1 Market Trends
  - 9.2.3.2 Market Forecast
- 9.2.4 South Korea
  - 9.2.4.1 Market Trends
  - 9.2.4.2 Market Forecast
- 9.2.5 Australia
  - 9.2.5.1 Market Trends
  - 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
  - 9.2.6.1 Market Trends
  - 9.2.6.2 Market Forecast
- 9.2.7 Others
  - 9.2.7.1 Market Trends
  - 9.2.7.2 Market Forecast
9.3 Europe
- 9.3.1 Germany
  - 9.3.1.1 Market Trends
  - 9.3.1.2 Market Forecast
- 9.3.2 France
  - 9.3.2.1 Market Trends
  - 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
  - 9.3.3.1 Market Trends
  - 9.3.3.2 Market Forecast
- 9.3.4 Italy
  - 9.3.4.1 Market Trends
  - 9.3.4.2 Market Forecast
- 9.3.5 Spain
  - 9.3.5.1 Market Trends
  - 9.3.5.2 Market Forecast
- 9.3.6 Russia
  - 9.3.6.1 Market Trends
  - 9.3.6.2 Market Forecast
- 9.3.7 Others
  - 9.3.7.1 Market Trends
  - 9.3.7.2 Market Forecast
9.4 Latin America
- 9.4.1 Brazil
  - 9.4.1.1 Market Trends
  - 9.4.1.2 Market Forecast
- 9.4.2 Mexico
  - 9.4.2.1 Market Trends
  - 9.4.2.2 Market Forecast
- 9.4.3 Others
  - 9.4.3.1 Market Trends
  - 9.4.3.2 Market Forecast
9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast

10 SWOT Analysis

10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
- 14.3.1 Alcon Inc.
  - 14.3.1.1 Company Overview
  - 14.3.1.2 Product Portfolio
  - 14.3.1.3 Financials
- 14.3.2 Bausch Health Companies Inc.
  - 14.3.2.1 Company Overview
  - 14.3.2.2 Product Portfolio
  - 14.3.2.3 Financials
  - 14.3.2.4 SWOT Analysis
- 14.3.3 Carl Zeiss Meditec AG (Carl-Zeiss-Stiftung)
  - 14.3.3.1 Company Overview
  - 14.3.3.2 Product Portfolio
  - 14.3.3.3 Financials
  - 14.3.3.4 SWOT Analysis
- 14.3.4 EyeKon Medical Inc.
  - 14.3.4.1 Company Overview
  - 14.3.4.2 Product Portfolio
- 14.3.5 Hoya Corporation
  - 14.3.5.1 Company Overview
  - 14.3.5.2 Product Portfolio
  - 14.3.5.3 Financials
  - 14.3.5.4 SWOT Analysis
- 14.3.6 HumanOptics AG
  - 14.3.6.1 Company Overview
  - 14.3.6.2 Product Portfolio
  - 14.3.6.3 Financials
- 14.3.7 Johnson & Johnson
  - 14.3.7.1 Company Overview
  - 14.3.7.2 Product Portfolio
  - 14.3.7.3 Financials
  - 14.3.7.4 SWOT Analysis
- 14.3.8 Lenstec Inc.
  - 14.3.8.1 Company Overview
  - 14.3.8.2 Product Portfolio
- 14.3.9 Rayner Intraocular Lenses Limited
  - 14.3.9.1 Company Overview
  - 14.3.9.2 Product Portfolio
- 14.3.10 STAAR Surgical Company
  - 14.3.10.1 Company Overview
  - 14.3.10.2 Product Portfolio
  - 14.3.10.3 Financials

简介目录图表

List of Figures

Figure 1: Global: Intraocular Lens Market: Sales Value (in Billion USD), 2020-2025
Figure 2: Global: Intraocular Lens Market Forecast: Sales Value (in Billion USD), 2026-2034
Figure 3: Global: Intraocular Lens Market: Breakup by Product (in %), 2025
Figure 4: Global: Intraocular Lens Market: Breakup by Material (in %), 2025
Figure 5: Global: Intraocular Lens Market: Breakup by End Use (in %), 2025
Figure 6: Global: Intraocular Lens Market: Breakup by Region (in %), 2025
Figure 7: Global: Intraocular Lens (Monofocal IOL) Market: Sales Value (in Million USD), 2020 & 2025
Figure 8: Global: Intraocular Lens (Monofocal IOL) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 9: Global: Intraocular Lens (Multifocal IOL) Market: Sales Value (in Million USD), 2020 & 2025
Figure 10: Global: Intraocular Lens (Multifocal IOL) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 11: Global: Intraocular Lens (Toric IOL) Market: Sales Value (in Million USD), 2020 & 2025
Figure 12: Global: Intraocular Lens (Toric IOL) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 13: Global: Intraocular Lens (Accommodative IOL) Market: Sales Value (in Million USD), 2020 & 2025
Figure 14: Global: Intraocular Lens (Accommodative IOL) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 15: Global: Intraocular Lens (Polymethylmethacrylate-PMMA) Market: Sales Value (in Million USD), 2020 & 2025
Figure 16: Global: Intraocular Lens (Polymethylmethacrylate-PMMA) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 17: Global: Intraocular Lens (Silicone) Market: Sales Value (in Million USD), 2020 & 2025
Figure 18: Global: Intraocular Lens (Silicone) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 19: Global: Intraocular Lens (Hydrophobic Acrylic) Market: Sales Value (in Million USD), 2020 & 2025
Figure 20: Global: Intraocular Lens (Hydrophobic Acrylic) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 21: Global: Intraocular Lens (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
Figure 22: Global: Intraocular Lens (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 23: Global: Intraocular Lens (Ophthalmic Clinics) Market: Sales Value (in Million USD), 2020 & 2025
Figure 24: Global: Intraocular Lens (Ophthalmic Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 25: Global: Intraocular Lens (Ambulatory Care Centers) Market: Sales Value (in Million USD), 2020 & 2025
Figure 26: Global: Intraocular Lens (Ambulatory Care Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 27: Global: Intraocular Lens (Eye Research Institutes) Market: Sales Value (in Million USD), 2020 & 2025
Figure 28: Global: Intraocular Lens (Eye Research Institutes) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 29: North America: Intraocular Lens Market: Sales Value (in Million USD), 2020 & 2025
Figure 30: North America: Intraocular Lens Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 31: United States: Intraocular Lens Market: Sales Value (in Million USD), 2020 & 2025
Figure 32: United States: Intraocular Lens Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 33: Canada: Intraocular Lens Market: Sales Value (in Million USD), 2020 & 2025
Figure 34: Canada: Intraocular Lens Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 35: Asia-Pacific: Intraocular Lens Market: Sales Value (in Million USD), 2020 & 2025
Figure 36: Asia-Pacific: Intraocular Lens Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 37: China: Intraocular Lens Market: Sales Value (in Million USD), 2020 & 2025
Figure 38: China: Intraocular Lens Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 39: Japan: Intraocular Lens Market: Sales Value (in Million USD), 2020 & 2025
Figure 40: Japan: Intraocular Lens Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 41: India: Intraocular Lens Market: Sales Value (in Million USD), 2020 & 2025
Figure 42: India: Intraocular Lens Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 43: South Korea: Intraocular Lens Market: Sales Value (in Million USD), 2020 & 2025
Figure 44: South Korea: Intraocular Lens Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 45: Australia: Intraocular Lens Market: Sales Value (in Million USD), 2020 & 2025
Figure 46: Australia: Intraocular Lens Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 47: Indonesia: Intraocular Lens Market: Sales Value (in Million USD), 2020 & 2025
Figure 48: Indonesia: Intraocular Lens Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 49: Others: Intraocular Lens Market: Sales Value (in Million USD), 2020 & 2025
Figure 50: Others: Intraocular Lens Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 51: Europe: Intraocular Lens Market: Sales Value (in Million USD), 2020 & 2025
Figure 52: Europe: Intraocular Lens Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 53: Germany: Intraocular Lens Market: Sales Value (in Million USD), 2020 & 2025
Figure 54: Germany: Intraocular Lens Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 55: France: Intraocular Lens Market: Sales Value (in Million USD), 2020 & 2025
Figure 56: France: Intraocular Lens Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 57: United Kingdom: Intraocular Lens Market: Sales Value (in Million USD), 2020 & 2025
Figure 58: United Kingdom: Intraocular Lens Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 59: Italy: Intraocular Lens Market: Sales Value (in Million USD), 2020 & 2025
Figure 60: Italy: Intraocular Lens Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 61: Spain: Intraocular Lens Market: Sales Value (in Million USD), 2020 & 2025
Figure 62: Spain: Intraocular Lens Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 63: Russia: Intraocular Lens Market: Sales Value (in Million USD), 2020 & 2025
Figure 64: Russia: Intraocular Lens Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 65: Others: Intraocular Lens Market: Sales Value (in Million USD), 2020 & 2025
Figure 66: Others: Intraocular Lens Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 67: Latin America: Intraocular Lens Market: Sales Value (in Million USD), 2020 & 2025
Figure 68: Latin America: Intraocular Lens Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 69: Brazil: Intraocular Lens Market: Sales Value (in Million USD), 2020 & 2025
Figure 70: Brazil: Intraocular Lens Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 71: Mexico: Intraocular Lens Market: Sales Value (in Million USD), 2020 & 2025
Figure 72: Mexico: Intraocular Lens Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 73: Others: Intraocular Lens Market: Sales Value (in Million USD), 2020 & 2025
Figure 74: Others: Intraocular Lens Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 75: Middle East and Africa: Intraocular Lens Market: Sales Value (in Million USD), 2020 & 2025
Figure 76: Middle East and Africa: Intraocular Lens Market: Breakup by Country (in %), 2025
Figure 77: Middle East and Africa: Intraocular Lens Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 78: Global: Intraocular Lens Industry: SWOT Analysis
Figure 79: Global: Intraocular Lens Industry: Value Chain Analysis
Figure 80: Global: Intraocular Lens Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Intraocular Lens Market: Key Industry Highlights, 2025 and 2034
Table 2: Global: Intraocular Lens Market Forecast: Breakup by Product (in Million USD), 2026-2034
Table 3: Global: Intraocular Lens Market Forecast: Breakup by Material (in Million USD), 2026-2034
Table 4: Global: Intraocular Lens Market Forecast: Breakup by End Use (in Million USD), 2026-2034
Table 5: Global: Intraocular Lens Market Forecast: Breakup by Region (in Million USD), 2026-2034
Table 6: Global: Intraocular Lens Market: Competitive Structure
Table 7: Global: Intraocular Lens Market: Key Players

02-2729-4219

+886-2-2729-4219

License/价格

人工水晶体市场报告：按产品、材料、应用和地区划分（2026-2034 年）

Intraocular Lens Market Report by Product, Material (Polymethylmethacrylate, Silicone, Hydrophobic Acrylic), End Use, and Region 2026-2034

市场规模及预测：

主要部分：

主要企业：

市场成长的主要驱动因素：

未来展望：

人工水晶体市场趋势：

目录

第一章：序言

第二章：调查方法

第三章执行摘要

第四章：引言

第五章：全球人工水晶体市场

第六章 市场区隔：依产品划分

第七章 市场区隔：依材料划分

第八章 市场区隔：依最终用途划分

第九章 市场区隔：依地区划分

第十章 SWOT 分析

第十一章：价值链分析

第十二章：波特五力分析

第十三章：价格分析

第十四章 竞争格局